drugset / Trial / NCT00767481

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

NCT00767481

Phase 3 Terminated 6 enrolled Alcon Research PPD Development, LP · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Parallel, Multi-Center, Double-masked, Active controlled, three arm study comparing the IOP lowering efficacy and safety over 12 months of morning or evening instillations of Travoprost/Brinzolamide vs. Cosopt dosed in the morning and evening in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2008-10
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule Topical
Comparator Cosopt Unknown Topical
Subject Travoprost Other / unclassified Topical